Structural Proteins, leucine-rich repeat
Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 12 |
NetGPI | no | yes: 0, no: 12 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005929 | cilium | 4 | 12 |
GO:0042995 | cell projection | 2 | 12 |
GO:0043226 | organelle | 2 | 12 |
GO:0043227 | membrane-bounded organelle | 3 | 12 |
GO:0110165 | cellular anatomical entity | 1 | 13 |
GO:0120025 | plasma membrane bounded cell projection | 3 | 12 |
GO:0005930 | axoneme | 2 | 1 |
Related structures:
AlphaFold database: A4HUC5
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_PCSK_SKI1_1 | 151 | 155 | PF00082 | 0.391 |
DEG_APCC_DBOX_1 | 53 | 61 | PF00400 | 0.362 |
DOC_CDC14_PxL_1 | 144 | 152 | PF14671 | 0.365 |
DOC_CKS1_1 | 160 | 165 | PF01111 | 0.462 |
DOC_CYCLIN_RxL_1 | 148 | 156 | PF00134 | 0.423 |
DOC_MAPK_gen_1 | 100 | 109 | PF00069 | 0.365 |
DOC_MAPK_gen_1 | 189 | 197 | PF00069 | 0.416 |
DOC_MAPK_MEF2A_6 | 191 | 199 | PF00069 | 0.425 |
DOC_MAPK_MEF2A_6 | 206 | 213 | PF00069 | 0.448 |
DOC_PP2B_LxvP_1 | 145 | 148 | PF13499 | 0.325 |
DOC_USP7_MATH_1 | 177 | 181 | PF00917 | 0.471 |
DOC_WW_Pin1_4 | 159 | 164 | PF00397 | 0.456 |
DOC_WW_Pin1_4 | 69 | 74 | PF00397 | 0.487 |
LIG_14-3-3_CanoR_1 | 106 | 110 | PF00244 | 0.377 |
LIG_14-3-3_CanoR_1 | 151 | 156 | PF00244 | 0.423 |
LIG_14-3-3_CanoR_1 | 74 | 81 | PF00244 | 0.423 |
LIG_Actin_WH2_2 | 77 | 94 | PF00022 | 0.487 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.570 |
LIG_BRCT_BRCA1_1 | 37 | 41 | PF00533 | 0.511 |
LIG_CSL_BTD_1 | 115 | 118 | PF09270 | 0.423 |
LIG_FHA_1 | 17 | 23 | PF00498 | 0.530 |
LIG_FHA_2 | 160 | 166 | PF00498 | 0.489 |
LIG_FHA_2 | 223 | 229 | PF00498 | 0.527 |
LIG_LIR_Gen_1 | 198 | 203 | PF02991 | 0.372 |
LIG_LIR_Gen_1 | 207 | 214 | PF02991 | 0.455 |
LIG_LIR_Gen_1 | 87 | 94 | PF02991 | 0.372 |
LIG_LIR_Nem_3 | 115 | 119 | PF02991 | 0.395 |
LIG_LIR_Nem_3 | 190 | 196 | PF02991 | 0.520 |
LIG_LIR_Nem_3 | 198 | 202 | PF02991 | 0.372 |
LIG_LIR_Nem_3 | 207 | 213 | PF02991 | 0.455 |
LIG_LIR_Nem_3 | 87 | 91 | PF02991 | 0.360 |
LIG_MAD2 | 151 | 159 | PF02301 | 0.444 |
LIG_PCNA_yPIPBox_3 | 103 | 117 | PF02747 | 0.444 |
LIG_Pex14_2 | 37 | 41 | PF04695 | 0.517 |
LIG_PTB_Apo_2 | 155 | 162 | PF02174 | 0.423 |
LIG_PTB_Phospho_1 | 155 | 161 | PF10480 | 0.444 |
LIG_SH2_CRK | 88 | 92 | PF00017 | 0.374 |
LIG_SH2_NCK_1 | 43 | 47 | PF00017 | 0.374 |
LIG_SH2_SRC | 174 | 177 | PF00017 | 0.557 |
LIG_SH2_STAT5 | 161 | 164 | PF00017 | 0.556 |
LIG_SH2_STAT5 | 174 | 177 | PF00017 | 0.557 |
LIG_SH2_STAT5 | 36 | 39 | PF00017 | 0.443 |
LIG_SH2_STAT5 | 43 | 46 | PF00017 | 0.425 |
LIG_SH2_STAT5 | 88 | 91 | PF00017 | 0.382 |
LIG_SUMO_SIM_anti_2 | 55 | 61 | PF11976 | 0.381 |
LIG_SUMO_SIM_par_1 | 151 | 156 | PF11976 | 0.343 |
LIG_SxIP_EBH_1 | 168 | 179 | PF03271 | 0.409 |
LIG_TRAF2_1 | 126 | 129 | PF00917 | 0.343 |
LIG_TRAF2_1 | 162 | 165 | PF00917 | 0.526 |
LIG_WRC_WIRS_1 | 196 | 201 | PF05994 | 0.371 |
MOD_CDK_SPK_2 | 69 | 74 | PF00069 | 0.487 |
MOD_CK1_1 | 87 | 93 | PF00069 | 0.494 |
MOD_CK1_1 | 96 | 102 | PF00069 | 0.360 |
MOD_CK2_1 | 10 | 16 | PF00069 | 0.679 |
MOD_CK2_1 | 159 | 165 | PF00069 | 0.476 |
MOD_CK2_1 | 222 | 228 | PF00069 | 0.531 |
MOD_CK2_1 | 99 | 105 | PF00069 | 0.404 |
MOD_GlcNHglycan | 182 | 186 | PF01048 | 0.562 |
MOD_GSK3_1 | 177 | 184 | PF00069 | 0.500 |
MOD_GSK3_1 | 31 | 38 | PF00069 | 0.392 |
MOD_GSK3_1 | 69 | 76 | PF00069 | 0.447 |
MOD_GSK3_1 | 90 | 97 | PF00069 | 0.457 |
MOD_N-GLC_1 | 41 | 46 | PF02516 | 0.497 |
MOD_N-GLC_1 | 84 | 89 | PF02516 | 0.351 |
MOD_NEK2_1 | 3 | 8 | PF00069 | 0.676 |
MOD_NEK2_1 | 35 | 40 | PF00069 | 0.401 |
MOD_NEK2_1 | 84 | 89 | PF00069 | 0.351 |
MOD_NEK2_2 | 31 | 36 | PF00069 | 0.497 |
MOD_PKA_2 | 73 | 79 | PF00069 | 0.433 |
MOD_PKA_2 | 99 | 105 | PF00069 | 0.408 |
MOD_PKB_1 | 149 | 157 | PF00069 | 0.444 |
MOD_Plk_1 | 84 | 90 | PF00069 | 0.355 |
MOD_Plk_1 | 94 | 100 | PF00069 | 0.367 |
MOD_Plk_4 | 10 | 16 | PF00069 | 0.662 |
MOD_Plk_4 | 112 | 118 | PF00069 | 0.444 |
MOD_Plk_4 | 170 | 176 | PF00069 | 0.511 |
MOD_Plk_4 | 198 | 204 | PF00069 | 0.454 |
MOD_Plk_4 | 31 | 37 | PF00069 | 0.430 |
MOD_ProDKin_1 | 159 | 165 | PF00069 | 0.461 |
MOD_ProDKin_1 | 69 | 75 | PF00069 | 0.481 |
TRG_ENDOCYTIC_2 | 193 | 196 | PF00928 | 0.396 |
TRG_ENDOCYTIC_2 | 43 | 46 | PF00928 | 0.380 |
TRG_ENDOCYTIC_2 | 88 | 91 | PF00928 | 0.348 |
TRG_ER_diArg_1 | 148 | 151 | PF00400 | 0.427 |
TRG_ER_diArg_1 | 188 | 191 | PF00400 | 0.469 |
TRG_ER_diArg_1 | 223 | 226 | PF00400 | 0.498 |
TRG_NES_CRM1_1 | 123 | 133 | PF08389 | 0.320 |
TRG_Pf-PMV_PEXEL_1 | 125 | 129 | PF00026 | 0.309 |
TRG_Pf-PMV_PEXEL_1 | 151 | 156 | PF00026 | 0.423 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P7B1 | Leptomonas seymouri | 63% | 100% |
A0A0S4J897 | Bodo saltans | 47% | 83% |
A0A0S4JIC5 | Bodo saltans | 29% | 73% |
A0A1X0NQ44 | Trypanosomatidae | 55% | 100% |
A0A3S7WQZ4 | Leishmania donovani | 99% | 100% |
A0A422NRS7 | Trypanosoma rangeli | 56% | 100% |
A4H5Z9 | Leishmania braziliensis | 84% | 100% |
C9ZVG5 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 58% | 100% |
E9AN24 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 91% | 100% |
Q32NT4 | Xenopus laevis | 26% | 68% |
Q4QHK2 | Leishmania major | 95% | 100% |
V5BIH6 | Trypanosoma cruzi | 55% | 100% |